PTC Therapeutics, Inc. (PTCT) earnings
PTCT earnings moved a median of -0.18% by the close. Quarterly and annual PTCT reports and results, each read against the price at its own news timestamp. Back to the PTCT overview →
30 measured PTCT earnings events.
Where these PTCT earnings landedvs 29 measured PTCT earnings reactions
| Middle 50% of PTCT earnings reactions | -2.98% to +3.45% |
|---|---|
| Median reaction (to close) | -0.18% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 PTCT earnings events with a measured close landed between -2.98% and +3.45%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026 | Press release | +0.24% | — | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | -7.27% | -7.75% | |
| PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results | Press release | -7.27% | -7.75% | |
| PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026 | Press release | -0.77% | -1.23% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | -4.59% | -0.51% | |
| PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results | Press release | -4.59% | -0.51% | |
| PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 | Press release | -1.50% | -0.35% | |
| Form 10-K PTC THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +1.04% | +3.23% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.34% | +2.53% | |
| PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results | Press release | -0.34% | +2.53% | |
| PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results | Press release | -0.59% | -1.52% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.98% | -3.20% | |
| PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results | Press release | +0.98% | -3.20% | |
| PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results | Press release | +0.23% | -3.27% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.18% | +3.45% | |
| PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results | Press release | +0.18% | +3.45% | |
| PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results | Press release | -0.24% | +2.29% | |
| Form 10-K PTC THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +11.56% | +23.38% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.35% | -2.98% | |
| PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results | Press release | -0.35% | -2.98% | |
| PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results | Press release | +0.45% | -3.04% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +5.51% | +6.50% | |
| PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results | Press release | +5.51% | +6.50% | |
| PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results | Press release | -0.22% | +0.00% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.17% | +5.82% | |
| PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results | Press release | -0.17% | +5.82% | |
| PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results | Press release | +0.16% | -0.18% | |
| Form 10-K PTC THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +9.02% | +20.57% | |
| Form 10-Q PTC THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | -2.72% | -4.39% | |
| PTC Therapeutics to Host Conference Call to Discuss?Third Quarter 2023 Financial Results? | Press release | +1.81% | +3.62% |
Keep exploring
More PTCT: analyst actions → · SEC filings → · PTCT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Tyme Technologies, Inc. (TYME) | 691 | -0.28% | 41% |
| Marinus Pharmaceuticals, Inc. (MRNS) | 687 | 0.00% | 50% |
| Gilead Sciences, Inc. (GILD) | 677 | -0.00% | 50% |
| ONCOMED PHARMACEUTICALS (OMED) | 677 | -0.20% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.